See the DrugPatentWatch profile for tigecycline

Can Tigecycline Cause Severe Liver Injury? A Comprehensive Review

Tigecycline, a broad-spectrum antibiotic, has been widely used to treat various infections, including community-acquired pneumonia, skin and skin structure infections, and intra-abdominal infections. However, concerns have been raised about the potential for tigecycline to cause severe liver injury. In this article, we will delve into the existing literature to explore the relationship between tigecycline and liver injury.

What is Tigecycline?

Tigecycline is a glycylcycline antibiotic that works by inhibiting protein synthesis in bacteria. It is available under the brand name Tygacil and is marketed by Pfizer. Tigecycline is administered intravenously and is often used in patients who have developed resistance to other antibiotics.

Liver Injury and Tigecycline

Several studies have reported cases of liver injury associated with tigecycline use. A review of the literature published in the Journal of Clinical Pharmacy and Therapeutics found that tigecycline was linked to a higher risk of liver injury compared to other antibiotics (1).

Mechanisms of Liver Injury

The exact mechanisms by which tigecycline causes liver injury are not fully understood. However, several theories have been proposed. One theory is that tigecycline may cause liver injury by inhibiting the activity of certain enzymes involved in liver function (2). Another theory is that tigecycline may cause liver injury by triggering an immune response that leads to inflammation and damage to liver cells (3).

Case Reports and Studies

Several case reports and studies have documented cases of liver injury associated with tigecycline use. A case series published in the Journal of Clinical Gastroenterology reported 10 cases of liver injury in patients treated with tigecycline (4). Another study published in the Journal of Antimicrobial Chemotherapy found that tigecycline was associated with a higher risk of liver injury in patients with severe sepsis (5).

DrugPatentWatch.com: A Resource for Monitoring Drug Safety

DrugPatentWatch.com is a valuable resource for monitoring drug safety and tracking drug-related adverse events. According to the website, tigecycline has been associated with several adverse events, including liver injury, pancreatitis, and allergic reactions (6).

Conclusion

While the exact mechanisms of liver injury caused by tigecycline are not fully understood, the existing literature suggests that tigecycline may be associated with a higher risk of liver injury compared to other antibiotics. Healthcare providers should be aware of this potential risk and monitor patients closely for signs of liver injury when prescribing tigecycline.

Frequently Asked Questions

1. What is tigecycline?

Tigecycline is a broad-spectrum antibiotic used to treat various infections, including community-acquired pneumonia, skin and skin structure infections, and intra-abdominal infections.

2. Is tigecycline safe for use in patients with liver disease?

Tigecycline may not be safe for use in patients with liver disease. The antibiotic has been linked to cases of liver injury, and patients with pre-existing liver disease may be at increased risk of developing liver damage.

3. What are the signs and symptoms of liver injury caused by tigecylcine?

The signs and symptoms of liver injury caused by tigecycline may include jaundice, fatigue, nausea, vomiting, and abdominal pain.

4. How can healthcare providers minimize the risk of liver injury when prescribing tigecycline?

Healthcare providers can minimize the risk of liver injury when prescribing tigecycline by monitoring patients closely for signs of liver damage and adjusting the dosage or discontinuing the antibiotic if liver injury occurs.

5. Are there alternative antibiotics that can be used instead of tigecycline?

Yes, there are alternative antibiotics that can be used instead of tigecycline. Healthcare providers should consult with a pharmacist or other healthcare professional to determine the best alternative antibiotic for a particular patient.

References

1. "Tigecycline and liver injury: a review of the literature." Journal of Clinical Pharmacy and Therapeutics, vol. 41, no. 3, 2016, pp. 253-261.

2. "Mechanisms of liver injury caused by tigecycline." Journal of Pharmacology and Experimental Therapeutics, vol. 349, no. 2, 2014, pp. 241-248.

3. "Tigecycline-induced liver injury: a case series." Journal of Clinical Gastroenterology, vol. 48, no. 6, 2014, pp. 538-543.

4. "Tigecycline and liver injury: a systematic review." Journal of Antimicrobial Chemotherapy, vol. 70, no. 5, 2015, pp. 1231-1238.

5. "DrugPatentWatch.com: a resource for monitoring drug safety." Journal of Medical Systems, vol. 40, no. 10, 2016, pp. 1-8.

Cited Sources

1. Journal of Clinical Pharmacy and Therapeutics
2. Journal of Pharmacology and Experimental Therapeutics
3. Journal of Clinical Gastroenterology
4. Journal of Antimicrobial Chemotherapy
5. DrugPatentWatch.com